GRI Bio, Inc.
GRI
$2.31
$0.062.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.96M | -11.25M | -10.01M | -9.37M | -8.21M |
| Total Depreciation and Amortization | 4.00K | 4.00K | 4.00K | 4.00K | 4.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 841.00K | 811.00K | 380.00K | 222.00K | 40.00K |
| Change in Net Operating Assets | 925.00K | 1.22M | 455.00K | 996.00K | -448.00K |
| Cash from Operations | -10.19M | -9.21M | -9.17M | -8.14M | -8.61M |
| Capital Expenditure | -3.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 15.56M | 9.94M | 9.35M | 8.37M | 13.87M |
| Repurchase of Common Stock | -2.00K | -1.00K | -2.00K | -2.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.17M | -1.41M | -1.41M | -1.03M | -2.03M |
| Cash from Financing | 13.39M | 8.52M | 7.94M | 7.33M | 11.83M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.20M | -691.00K | -1.23M | -810.00K | 3.22M |